 |
Editor: Nancy K. Mello, PhD
ISSN: 1064-1297
Published Bimonthly, beginning in February
|
Please consult APA's Instructions for All Authors for information regarding
Submit manuscripts electronically through the Manuscript Submission Portal (.rtf or .doc). Submissions mailed to the editorial office will not be processed. General correspondence may be directed to:
Nancy K. Mello, PhD, Editor
Alcohol and Drug Abuse Research Center
McLean Hospital—Harvard Medical School
115 Mill Street
Belmont, MA 02478-9106
E-mail:
Editorial Office |
 |
In addition to complete addresses and phone numbers, please supply email addresses and fax numbers for all authors for potential use by the editorial office and, later, by the production office.
Experimental and Clinical Psychopharmacology publishes three types of manuscripts: (1) Original Research Reports, (2) Reviews of the Literature, and (3) Innovations in Psychopharmacology. Innovations in Psychopharmacology is published occasionally to report a novel method, a novel result, or a novel measure. Commentary on the nature and implications of the innovation may be invited.
Include the corresponding author's e-mail and mailing address, phone and fax numbers, and the names, degrees, and affiliations of all authors, as well as the number of figures and tables in the manuscript.
All manuscripts must include an abstract containing a maximum of 250 words typed on a separate page. After the abstract, please supply up to five keywords or brief phrases.
The sources of financial support, the assistance of colleagues, and other related information should appear in a single paragraph on a separate page after the abstract.
Authors may suggest up to five scientists who are qualified to review their manuscript without bias or conflict of interest. Send prospective reviewers' names, affiliations, academic rank, e-mail, complete mailing address, and phone number in your cover letter.
|
